Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex.

MLA

Feng, Yongmei, et al. “Inhibition of Coronavirus HCoV-OC43 by Targeting the EIF4F Complex.” Frontiers in Pharmacology, vol. 13, Dec. 2022, p. 1029093. EBSCOhost, https://doi.org/10.3389/fphar.2022.1029093.

APA

Feng, Y., Grotegut, S., Jovanovic, P., Gandin, V., Olson, S. H., Murad, R., Beall, A., Colayco, S., De-Jesus, P., Chanda, S., English, B. P., Singer, R. H., Jackson, M., Topisirovic, I., & Ronai, Z. A. (2022). Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex. Frontiers in Pharmacology, 13, 1029093. https://doi.org/10.3389/fphar.2022.1029093

Chicago

Feng, Yongmei, Stefan Grotegut, Predrag Jovanovic, Valentina Gandin, Steven H Olson, Rabi Murad, Anne Beall, et al. 2022. “Inhibition of Coronavirus HCoV-OC43 by Targeting the EIF4F Complex.” Frontiers in Pharmacology 13 (December): 1029093. doi:10.3389/fphar.2022.1029093.